$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000165495422003580 Filed on March 22, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$3.594K	$3.424M	$13.88M
YoY Change	-99.89%	16.54%	20.36%
Cost Of Revenue	$2.795M	$2.512M	$9.502M
YoY Change	16.94%	27.65%	33.41%
Gross Profit	$798.4K	$911.9K	$4.383M
YoY Change	-9.0%	-5.99%	-0.69%
Gross Profit Margin	22215.64%	26.63%	31.57%
Selling, General & Admin	$504.3K	$506.0K	$1.791M
YoY Change	8.91%	9.9%	4.28%
% of Gross Profit	63.16%	55.49%	40.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$522.2K	$262.7K	$1.330M
YoY Change	158.77%	41.57%	-7.21%
% of Gross Profit	65.4%	28.81%	30.34%
Operating Expenses	$904.2K	$2.512M	$9.502M
YoY Change	55.13%	27.65%	33.41%
Operating Profit	-$106.00	$264.0K	$1.744M
YoY Change	-100.04%	-35.77%	-24.65%
Interest Expense	-$345.4K	$343.2K	$1.362M
YoY Change	2.48%	4.68%	-28.87%
% of Operating Profit		129.99%	78.09%
Other Income/Expense, Net	$0.00	$3.160M	$0.00
YoY Change	-100.0%	25.08%	-100.0%
Pretax Income	-$451.00	-$79.00K	$382.0K
YoY Change	-99.99%	-195.18%	-108.41%
Income Tax	-$127.5K	$0.00	-$127.5K
% Of Pretax Income			-33.38%
Net Earnings	-$324.00	-$79.00K	$509.5K
YoY Change	-99.99%	-195.18%	-109.47%
Net Earnings / Revenue	-9.02%	-2.31%	3.67%
Basic Earnings Per Share	-$0.01	$0.00	$0.02
Diluted Earnings Per Share	-$0.01	$0.00	$0.02
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares	22.22M shares
Diluted Shares Outstanding		23.52M shares	23.64M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.264M	$1.789M	$1.264M
YoY Change	5.79%	8.77%	5.79%
Cash & Equivalents	$1.264M	$1.789M
Short-Term Investments
Other Short-Term Assets	$415.3K	$371.9K	$415.3K
YoY Change	4.9%	-25.56%	4.9%
Inventory	$994.1K	$919.2K	$994.1K
Prepaid Expenses	$415.3K	$371.8K
Receivables	$324.4K	$931.0K	$904.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.577M	$4.011M	$3.577M
YoY Change	6.46%	0.28%	6.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.150M	$4.642M	$11.15M
YoY Change	13.21%	-44.1%	4.85%
Goodwill	$278.5K	$278.5K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$324.4K	$281.9K	$4.042M
YoY Change	60.63%	-94.18%	2.63%
Total Long-Term Assets	$15.80M	$14.80M	$15.80M
YoY Change	4.93%	-20.25%	4.93%
TOTAL ASSETS
Total Short-Term Assets	$3.577M	$4.011M	$3.577M
Total Long-Term Assets	$15.80M	$14.80M	$15.80M
Total Assets	$19.38M	$18.81M	$19.38M
YoY Change	5.21%	-16.61%	5.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$919.2K	$482.6K	$919.2K
YoY Change	4.45%	-11.39%	4.68%
Accrued Expenses	$656.2K	$393.5K	$656.2K
YoY Change	59.26%	14.79%	59.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.575M	$876.1K	$1.575M
YoY Change	22.11%	-1.28%	22.11%
LONG-TERM LIABILITIES
Long-Term Debt	$8.496M	$8.381M	$8.496M
YoY Change	5.63%	5.64%	5.63%
Other Long-Term Liabilities	$6.410M	$6.344M	$6.410M
YoY Change	-4.71%	15.76%	-4.71%
Total Long-Term Liabilities	$14.91M	$14.73M	$14.91M
YoY Change	0.92%	9.77%	0.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.575M	$876.1K	$1.575M
Total Long-Term Liabilities	$14.91M	$14.73M	$14.91M
Total Liabilities	$16.48M	$15.60M	$16.48M
YoY Change	2.62%	9.09%	2.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.90M	-$21.57M
YoY Change	-2.27%
Common Stock	$24.79M	$24.78M
YoY Change	0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.895M	$3.211M	$2.895M
YoY Change
Total Liabilities & Shareholders Equity	$19.38M	$18.81M	$19.38M
YoY Change	5.21%	-16.61%	5.21%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	-$324.00	-$79.00K	$509.5K
YoY Change	-99.99%	-195.18%	-109.47%
Depreciation, Depletion And Amortization	$522.2K	$262.7K	$1.330M
YoY Change	158.77%	41.57%	-7.21%
Cash From Operating Activities	$357.6K	$275.3K	$1.519M
YoY Change	-47.77%	-4.69%	-9.36%
INVESTING ACTIVITIES
Capital Expenditures	-$883.4K	-$502.7K	$1.450M
YoY Change	-21.94%	134.09%	-30.46%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$883.4K	-$502.7K	-$1.450M
YoY Change	-21.94%	134.09%	-30.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	357.6K	275.3K	$1.519M
Cash From Investing Activities	-883.4K	-502.7K	-$1.450M
Cash From Financing Activities	0.000	0.000	$0.00
Net Change In Cash	-525.8K	-227.4K	$69.15K
YoY Change	16.65%	-436.24%	-92.92%
FREE CASH FLOW
Cash From Operating Activities	$357.6K	$275.3K	$1.519M
Capital Expenditures	-$883.4K	-$502.7K	$1.450M
Free Cash Flow	$1.241M	$777.9K	$69.15K
YoY Change	-31.68%	54.49%	-116.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Firm AuditorFirmId	752
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1263513	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6538359	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7516941	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18416940	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19375757	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1575303	USD
CY2020Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	7468709	USD
CY2021Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	7898941	USD
CY2020Q4	nrom	Corbel Warrant Value CorbelWarrantValue	29037	USD
CY2021Q4	nrom	Corbel Warrant Value CorbelWarrantValue	29037	USD
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	597229	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5570639	USD
CY2020Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	834018	USD
CY2021Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	810044	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14905890	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	24791568	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21897004	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1290104	USD
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	574479	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5863615	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14769858	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	24763447	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22406469	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2356978	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18416940	USD
CY2021	nrom	Franchising Expenses FranchisingExpenses	1810363	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	7122043	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	9501665	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	382793	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	382368	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1739383	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-378065	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020	us-gaap	Interest Expense InterestExpense	1914344	USD
CY2021	us-gaap	Interest Expense InterestExpense	1361625	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19375757	USD
CY2019	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	4830199	USD
CY2020	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	6209279	USD
CY2021	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	8939569	USD
CY2019	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	673647	USD
CY2020	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	470846	USD
CY2021	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	485595	USD
CY2019	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	6162576	USD
CY2020	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	4841229	USD
CY2021	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	4444826	USD
CY2019	nrom	Administrative Fees And Other AdministrativeFeesAndOther	38202	USD
CY2020	nrom	Administrative Fees And Other AdministrativeFeesAndOther	14310	USD
CY2021	nrom	Administrative Fees And Other AdministrativeFeesAndOther	14898	USD
CY2019	us-gaap	Revenues Revenues	11704624	USD
CY2020	us-gaap	Revenues Revenues	11535664	USD
CY2021	us-gaap	Revenues Revenues	13884888	USD
CY2019	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	4250406	USD
CY2020	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	4938133	USD
CY2021	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	7224833	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	626453	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	447040	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	466469	USD
CY2019	nrom	Franchising Expenses FranchisingExpenses	2092001	USD
CY2020	nrom	Franchising Expenses FranchisingExpenses	1736870	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	6968860	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	848913	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1717209	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1790722	USD
CY2019	nrom	Non Operating Expenses NonOperatingExpenses	9091036	USD
CY2020	nrom	Non Operating Expenses NonOperatingExpenses	9221620	USD
CY2021	nrom	Non Operating Expenses NonOperatingExpenses	12141300	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	2613588	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	2314044	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1743588	USD
CY2019	us-gaap	Interest Expense InterestExpense	774565	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1300000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4941718	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	539023	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4542018	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	381963	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	917088	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	839928	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-127502	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22052859	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23465512	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23641678	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	8145336	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-378065	USD
CY2019	nrom	New Accounting Pronouncement Or Change In Accounting Principles Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrinciplesEffectOfAdoptionQuantification	-52312	USD
CY2019	nrom	Amortization Of Value Of Stockoptions AmortizationOfValueOfStockoptions	18829	USD
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1385194	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	USD
CY2020	nrom	Write Off Unamortized Closing To Sub Debt That Was Converted WriteOffUnamortizedClosingToSubDebtThatWasConverted	-116400	USD
CY2020	nrom	Amortization Of Value Of Stockoptions AmortizationOfValueOfStockoptions	21536	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2356978	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	USD
CY2021	nrom	Amortization Of Value Of Stockoptions AmortizationOfValueOfStockoptions	28121	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-378065	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	USD
CY2019	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	469804	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1433295	USD
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1330017	USD
CY2019	nrom	Amortization Of Lease Cost In Excess Of Cash Paid AmortizationOfLeaseCostInExcessOfCashPaid	134545	USD
CY2020	nrom	Amortization Of Lease Cost In Excess Of Cash Paid AmortizationOfLeaseCostInExcessOfCashPaid	46994	USD
CY2021	nrom	Amortization Of Lease Cost In Excess Of Cash Paid AmortizationOfLeaseCostInExcessOfCashPaid	36223	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	917088	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	839928	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-127502	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	377151	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	98388	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-82123	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9896	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	103530	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	96392	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-189884	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	19391	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-548648	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4508836	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	122440	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	207745	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147040	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	41058	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1508345	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1675747	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1518929	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	289351	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2084710	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1449779	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-289351	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2084710	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1449779	USD
CY2019	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	998271	USD
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	4379024	USD
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0	USD
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7039218	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	78785	USD
CY2020	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	0	USD
CY2021	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1077056	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	141938	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	976231	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69150	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76194	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	218132	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1194363	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	218132	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1194363	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1263513	USD
CY2016Q4	nrom	Number Of Issued Units NumberOfIssuedUnits	32	integer
CY2016Q4	nrom	Purchase Price Shares PurchasePriceShares	50000	USD
CY2016	nrom	Aggregate Shares Of Note Payable AggregateSharesOfNotePayable	1600000	USD
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.57
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5319446	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23465512	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	571965	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Use of Estimates: The preparation of the consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. After a thorough review by management in 2018, the Company permanently wrote off $1.3 million and created an additional reserve for possible non-collection of $2.8 million. After a review in 2019 and also considering the impact of the COVID-19 pandemic, it was decided to add an additional reserve of $1.3 million for possible non-collections. In 2020, in light of the additional uncertainty created as a result of the COVID-19 pandemic, the Company decided to create a reserve for uncollectability on all long-term franchisee receivables. The Company will continue to pursue collection where circumstances are appropriate and all collections of these receivables in the future will result in additional income at the time received. The Company evaluates its property and equipment and related costs periodically to assess whether any impairment indications are present, including recurring operating losses and significant adverse changes in legal factors or business climate that affect the recovery of recorded value. If any impairment of an individual asset is evident, a loss would be provided to reduce the carrying value to its estimated fair value. </p>
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	1300000	USD
CY2021Q4	nrom	Additional Reserve For Noncollection AdditionalReserveForNoncollection	2800000	USD
CY2021Q4	nrom	Additional Reserve AdditionalReserve	1300000	USD
CY2021Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	574776	USD
CY2021	us-gaap	Revenue Recognition Services Franchise Fees RevenueRecognitionServicesFranchiseFees	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Royalties, Administrative and Franchise Fees: Royalties are generally recognized as income monthly based on a percentage of monthly sales of franchised or licensed restaurants and from audits and other inspections as they come due and payable by the franchisee. Fees from the retail products in grocery stores are recognized monthly based on the distributors’ sale of those retail products to the grocery stores or grocery store distributors. Administrative fees are recognized as income monthly as earned. The Company adopted Accounting Standards Updated (“ASU”) 2014-09 effective January 2018 which did not materially affect the Company's recognition of royalties, fees from the sale of retail products in grocery stores, administrative fees or sales from Company-owned restaurants. However, initial franchise fees and related contract costs are now deferred and amortized on a straight-line basis over the term of the franchise agreements, generally five to ten years. The effect to comparable periods within the financial statements is not material as the initial franchise fee for the non-traditional franchise is intended to defray the initial contract cost, and the franchise fees and contract costs initially incurred and paid approximate the relative amortized franchise fees and contract costs for those same periods.</p>
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23315695	shares
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1700000	USD
CY2020	nrom	Additional Tax Expense AdditionalTaxExpense	267528	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	572400	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-378065	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22052859	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2019	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-316105	USD
CY2021Q4	nrom	Line Of Credit Principal LineOfCreditPrincipal	8474985	USD
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	547007	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	696000	USD
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7927978	USD
CY2017Q1	nrom	Number Of Issued Units NumberOfIssuedUnits	16	integer
CY2017Q1	nrom	Purchase Price Shares PurchasePriceShares	800000	USD
CY2021	nrom	Unsecured Promissory Note UnsecuredPromissoryNote	50000	USD
CY2021Q4	nrom	Warrant Purchase Shares WarrantPurchaseShares	50000	shares
CY2021Q4	nrom	Aggregate Principal Amount Of Note Payable AggregatePrincipalAmountOfNotePayable	50000	USD
CY2021Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3200000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.66
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.66
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.70
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	18829	USD
CY2019	nrom	Tax Benefit TaxBenefit	4995	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	21536	USD
CY2020	nrom	Tax Benefit TaxBenefit	5168	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	28119	USD
CY2021	nrom	Description Of Interest On Accrued Notes DescriptionOfInterestOnAccruedNotes	the Company offered to extend the maturity of the Notes and the expiration date of the Warrants to January 2023. Certain of the holders of the Notes and Warrants accepted the Company’s offer. Accordingly, of the principal amount of the Notes, holders of $775,000 in principal amount extended their Notes until January 31, 2023. In 2018 and 2019, holders of $500,000 in principal amount of the Notes converted those Notes to 1,000,000 shares of the Company’s Common Stock in accordance with the terms of the Note. In February 2020, in conjunction with the Company’s refinancing of its debt, $1,275,000 in principal amount of those Notes was repaid leaving a balance of $625,000 which mature on January 31, 2023. The holders of the remaining $625,000 principal amount of Notes can elect, at their option any time prior to maturity, convert those Notes to Common Stock in accordance with the terms of the Notes.
CY2020Q1	nrom	Description Of Warrant Price DescriptionOfWarrantPrice	Warrants at a price of $0.001 per share of Common Stock subject to the Warrant upon 30 days’ notice if the daily average weighted trading price of the Common Stock equals or exceeds $2.00 per share for a period of 30 consecutive trading days.
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	625000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	597229	USD
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1360000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1900000	USD
CY2021	nrom	Tax Benefit TaxBenefit	6861	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	50941	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P36Y
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-337000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-5906000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	83000	USD
CY2021	us-gaap	Revenue Recognition Services Royalty Fees RevenueRecognitionServicesRoyaltyFees	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 4: Royalties and Fees</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Approximately $307,000, $198,000 and $204,000 are included in 2019, 2020 and 2021, respectively, royalties and fees in the Consolidated Statements of Operations for amortized initial franchise fees. Also included in royalties and fees were approximately $70,000, $45,000 and $32,000 in 2019, 2020 and 2021, respectively, for equipment commissions. Most of the cost for the services required to be performed by the Company are incurred prior to the franchise fee income being recorded which is based on contractual liability for the franchisee. Such incremental costs, include training, design and related travel cost to new franchises. The deferred contract income and costs approximated $834,000 on December 31, 2020 and $810,000 on December 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In conjunction with the development of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, the Company has devised its own recipes for many of the ingredients that go into the making of its products (“Proprietary Products”). The Company contracts with various manufacturers to manufacture its Proprietary Products in accordance with the Company’s recipes and formulas and to sell those products to authorized distributors at a contract price which includes an allowance for use of the Company’s recipes. The manufacturing contracts also require the manufacturers to hold those allowances in trust and to remit those allowances to the Company on a periodic basis, usually monthly. The Company recognizes those allowances in revenue as earned based on sales reports from the distributors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">There were 3,069 franchised/licensed or Company-owned outlets in operation on December 31, 2021 and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">3,064 on December 31, 2020. During 2021, 24 new franchised/licensed were opened and 19 franchised outlets left the system. Grocery stores are accustomed to adding products for a period of time, removing them for a period of time and possibly re-offering them. Therefore, it is unknown how many grocery store licenses, out of the total count of 2,403, have left the system.</p>
CY2020Q4	nrom	Deferred Contract Income And Costs DeferredContractIncomeAndCosts	834000	USD
CY2021Q4	nrom	Deferred Contract Income And Costs DeferredContractIncomeAndCosts	810000	USD
CY2021Q4	us-gaap	Number Of Stores NumberOfStores	3069	integer
CY2020Q4	us-gaap	Number Of Stores NumberOfStores	3064	integer
CY2021	nrom	Number Of Stores Opened NumberOfStoresOpened	24	integer
CY2021	nrom	Number Of Stores Closed NumberOfStoresClosed	19	integer
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	15370000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	656000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4130000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	9130000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1500000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2021	nrom	Weighted Average Lease Term WeightedAverageLeaseTerm	P7Y3M18D
CY2021	us-gaap	Lease Cost LeaseCost	36222	USD
CY2021	us-gaap	Gain Loss On Sale Of Leased Assets Net Operating Leases GainLossOnSaleOfLeasedAssetsNetOperatingLeases	12000000.0	USD
CY2021Q4	nrom	Outstanding Principal Balance OutstandingPrincipalBalance	625000	USD
CY2021Q4	nrom	Convertible Note Common Stock Price Per Shares ConvertibleNoteCommonStockPricePerShares	0.50
CY2020Q3	us-gaap	Revenues Revenues	2938000	USD
CY2020Q2	us-gaap	Revenues Revenues	2610000	USD
CY2020Q1	us-gaap	Revenues Revenues	2719000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	295000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	411000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3100000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1019000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	589000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4984000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	83000	USD
CY2021	nrom	Warrants Purchase Shares WarrantsPurchaseShares	775000	shares
CY2021	nrom	Maturity Date MaturityDate	February 2023
CY2021	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2250000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3813667	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.20	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0168	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0282	pure
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3643667	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	529500	shares
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	195000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3978167	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	443500	shares
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4421667	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	463500	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4855167	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	529500	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	325000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	195000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	731336	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	443500	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	212500	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	962336	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	463500	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	354336	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	30000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1041500	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.58
CY2021	nrom	Additional Expense For Rent AdditionalExpenseForRent	36222	USD
CY2021Q4	nrom	Aggregate Principal Amount Of Note Payable AggregatePrincipalAmountOfNotePayable	50000	USD
CY2021Q4	nrom	Warrant Purchase Shares WarrantPurchaseShares	50000	shares
CY2021Q4	us-gaap	Revenues Revenues	3594	USD
CY2021Q3	us-gaap	Revenues Revenues	3424000	USD
CY2021Q2	us-gaap	Revenues Revenues	3585000	USD
CY2021Q1	us-gaap	Revenues Revenues	3282000	USD
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-106	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	264000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	424000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1162000	USD
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-451	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-79000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	85000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	827000	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-324	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-79000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	85000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	827000	USD
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2020Q4	us-gaap	Revenues Revenues	3268000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	696000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-255000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01

Files In Submission

Name	View Source	Status
0001654954-22-003580-index-headers.html	Edgar Link	pending
0001654954-22-003580-index.html	Edgar Link	pending
0001654954-22-003580.txt	Edgar Link	pending
0001654954-22-003580-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20211231.xsd	Edgar Link	pending
nrom-20211231_cal.xml	Edgar Link	unprocessable
nrom-20211231_def.xml	Edgar Link	unprocessable
nrom-20211231_lab.xml	Edgar Link	unprocessable
nrom-20211231_pre.xml	Edgar Link	unprocessable
nrom_10k.htm	Edgar Link	pending
nrom_10k_htm.xml	Edgar Link	completed
nrom_ex311.htm	Edgar Link	pending
nrom_ex312.htm	Edgar Link	pending
nrom_ex321.htm	Edgar Link	pending
nrom_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2021 Q4 Form 10-K Financial Statement

#000165495422003580 Filed on March 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2021 Q4 Form 10-K Financial Statement

#000165495422003580 Filed on March 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom